High Tower Advisors, LLC Akebia Therapeutics, Inc. Transaction History

High Tower Advisors, LLC

$71.3 Billion
Q1 2025

A detailed history of High Tower Advisors, LLC transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 126,100 shares of AKBA stock, worth $371,995. This represents 0.0% of its overall portfolio holdings.

Number of Shares

126,100

Previous 93,350 35.08%

Holding current value

$371,995

Previous $173,000 39.88%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$1.69 - $2.84 $55,347 - $93,010	32,750 Added 35.08%	126,100 $242,000
Q3 2024 Nov 14, 2024	BUY	$0.94 - $1.55 $4,700 - $7,750	5,000 Added 5.66%	93,350 $123,000
Q2 2024 Aug 13, 2024	BUY	$0.86 - $1.63 $12,900 - $24,450	15,000 Added 20.45%	88,350 $90,000
Q1 2024 May 06, 2024	SELL	$1.27 - $2.24 $29,210 - $51,520	-23,000 Reduced 23.87%	73,350 $134,000
Q4 2023 Feb 12, 2024	BUY	$0.8 - $1.28 $800 - $1,280	1,000 Added 1.05%	96,350 $119,000
Q3 2023 Nov 08, 2023	BUY	$0.87 - $1.84 $21,750 - $46,000	25,000 Added 35.54%	95,350 $108,000
Q1 2023 May 11, 2023	BUY	$0.56 - $1.15 $6,118 - $12,563	10,925 Added 18.38%	70,350 $39,000
Q4 2022 Feb 08, 2023	BUY	$0.25 - $0.58 $1,850 - $4,292	7,401 Added 14.23%	59,425 $34,000
Q3 2022 Nov 09, 2022	BUY	$0.3 - $0.46 $1,890 - $2,898	6,300 Added 13.78%	52,024 $16,000
Q2 2022 Aug 10, 2022	SELL	$0.32 - $0.67 $946 - $1,981	-2,958 Reduced 6.08%	45,724 $16,000
Q1 2022 May 12, 2022	SELL	$0.72 - $2.93 $7 - $32	-11 Reduced 0.02%	48,682 $35,000
Q3 2021 Nov 12, 2021	SELL	$2.35 - $3.88 $1,057 - $1,746	-450 Reduced 0.92%	48,693 $141,000
Q1 2021 May 10, 2021	SELL	$2.92 - $5.06 $998 - $1,730	-342 Reduced 0.69%	49,143 $167,000
Q4 2020 Feb 10, 2021	SELL	$2.22 - $3.78 $5,665 - $9,646	-2,552 Reduced 4.9%	49,485 $139,000
Q3 2020 Nov 13, 2020	BUY	$2.39 - $13.08 $37,716 - $206,415	15,781 Added 43.53%	52,037 $129,000
Q2 2020 Aug 10, 2020	BUY	$6.67 - $13.58 $3,001 - $6,111	450 Added 1.26%	36,256 $493,000
Q4 2019 Feb 14, 2020	BUY	$3.16 - $6.73 $59,645 - $127,028	18,875 Added 111.48%	35,806 $226,000
Q3 2019 Nov 12, 2019	BUY	$3.55 - $5.4 $2,676 - $4,071	754 Added 4.66%	16,931 $66,000
Q2 2019 Aug 13, 2019	BUY	$4.1 - $8.05 $66,325 - $130,224	16,177 New	16,177 $79,000

Others Institutions Holding AKBA

# of Institutions

157

Shares Held

96.8M

Call Options Held

98.6K

Put Options Held

320K

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $542M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Akebia Therapeutics, Inc. Transaction History